Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
Very late-onset cytomegalovirus disease with ganciclovir resistance >15 years following renal transplantation
Khan, SF; Yong, MK; Slavin, MA; Hughes, P; Sasadeusz, J
(2021), Transpl. Infect. Dis.
DOI: 10.1111/tid.13441
Hepatitis B related dilemmas in the renal unit
Holt, SG; Locarnini, S; Sasadeusz, J
(2021), Nephrology, 287-293
DOI: 10.1111/nep.13815
A vaccination update for rheumatologists-SARS-CoV-2, influenza and herpes zoster
Wong, PKK; Lahiri, M; Lye, DC; Johnson, D; Charles, PGP
(2021), Int. J. Rheum. Dis., 979-983
Systematic review of M. Bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis
Muhi, S; Stinear, TP
(2021), Vaccine, 7238-7252
Partial oral antibiotic treatment for bacterial brain abscess: an open-label randomized non-inferiority trial (ORAL)
Bodilsen, J; Brouwer, MC; van de Beek, D; Tattevin, P; Tong, S; Naucler, P; Nielsen, H
(2021), Trials
A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol
Kuut, TA; Muller, F; Aldenkamp, A; Assmann-Schuilwerve, E; Braamse, A; Geerlings, SE; Gibney, KB; Kanaan, RAA; Nieuwkerk, P; Hartman, TCO; Pauelsen, D; Prins, M; Slieker, K; Van Vugt, M; Bleeker-Rovers, CP; Keijmel, SP; Knoop, H
(2021), Trials
American Society for Transplantation and Cellular Therapy Series: #4-Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation
Yong, MK; Shigle, TL; Kim, YJ; Carpenter, PA; Chemaly, RF; Papanicolaou, GA
(2021), Transpl. Cell. Ther., 957-967
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians
Hensen, L; Nguyen, THO; Rowntree, LC; Damelang, T; Koutsakos, M; Aban, M; Hurt, A; Harland, KL; Auladell, M; van de Sandt, CE; Everitt, A; Blacker, C; Oyong, DA; Loughland, JR; Webb, JR; Wines, BD; Hogarth, PM; Flanagan, KL; Plebanski, M; Wheatley, A; Chung, AW; Kent, SJ; Miller, A; Clemens, EB; Doherty, PC; Nelson, J; Davies, J; Tong, SYC; Kedzierska, K
(2021), Proc. Natl. Acad. Sci. U. S. A.
Longitudinal whole-genome based comparison of carriage and infection associated Staphylococcus aureus in northern Australian dialysis clinics
Holt, DC; Harris, TM; Hughes, JT; Lilliebridge, R; Croker, D; Graham, S; Hall, H; Wilson, J; Tong, SYC; Giffard, PM
(2021), PLoS One
Excess cost of care associated with sepsis in cancer patients: Results from a population-based case-control matched cohort
Tew, M; Dalziel, K; Thursky, K; Krahn, M; Abrahamyan, L; Morris, AM; Clarke, P
(2021), PLoS One
Seropositivity and geographical distribution of Strongyloides stercoralis in Australia: A study of pathology laboratory data from 2012-2016
Shield, J; Braat, S; Watts, M; Robertson, G; Beaman, M; McLeod, J; Baird, RW; Hart, J; Robson, J; Lee, R; McKessar, S; Nicholson, S; Mayer-Coverdale, J; Biggs, BA
(2021), Plos Neglect. Trop. Dis.
Genomic sequencing of hypervirulent Klebsiella pneumoniae with novel patterns of virulence and global epidemiological linkage
Khan, SF; Lacey, JA; Gorrie, C; Tong, SYC
(2021), Pathology, 682-685
Corynebacterium accolens Has Antimicrobial Activity against Staphylococcus aureus and Methicillin-Resistant S. aureus Pathogens Isolated from the Sinonasal Niche of Chronic Rhinosinusitis Patients
Menberu, MA; Liu, S; Cooksley, C; Hayes, AJ; Psaltis, AJ; Wormald, PJ; Vreugde, S
(2021), Pathogens
Diagnostic accuracy of a novel enzyme-linked immunoassay for the detection of IgG and IgG4 against Strongyloides stercoralis based on the recombinant antigens NIE/SsIR
Tamarozzi, F; Longoni, SS; Mazzi, C; Pettene, S; Montresor, A; Mahanty, S; Bisoffi, Z; Buonfrate, D
(2021), Parasites Vectors
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV
Lazarus, JV; Safreed-Harmon, K; Kamarulzaman, A; Anderson, J; Leite, RB; Behrens, G; Bekker, LG; Bhagani, S; Brown, D; Brown, G; Buchbinder, S; Caceres, C; Cahn, PE; Carrieri, P; Caswell, G; Cooke, GS; Monforte, Ad; Dedes, N; del Amo, J; Elliott, R; El-Sadr, WM; Fuster-Ruiz de Apodaca, MJ; Guaraldi, G; Hallett, T; Harding, R; Hellard, M; Jaffar, S; Kall, M; Klein, M; Lewin, SR; Mayer, K; Perez-Molina, JA; Moraa, D; Naniche, D; Nash, D; Noori, T; Pozniak, A; Rajasuriar, R; Reiss, P; Rizk, N; Rockstroh, J; Romero, D; Sabin, C; Serwadda, D; Waters, L
(2021), Nat. Commun.
CD8(+) T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
Hensen, L; Illing, PT; Clemens, EB; Nguyen, THO; Koutsakos, M; van de Sandt, CE; Mifsud, NA; Nguyen, AT; Szeto, C; Chua, BY; Halim, H; Rizzetto, S; Luciani, F; Loh, L; Grant, EJ; Saunders, PM; Brooks, AG; Rockman, S; Kotsimbos, TC; Cheng, AC; Richards, M; Westall, GP; Wakim, LM; Loudovaris, T; Mannering, SI; Elliott, M; Tangye, SG; Jackson, DC; Flanagan, KL; Rossjohn, J; Gras, S; Davies, J; Miller, A; Tong, SYC; Purcell, AW; Kedzierska, K
(2021), Nat. Commun.
Clinical and Molecular Epidemiology of an Emerging Panton-Valentine Leukocidin-Positive ST5 Methicillin-Resistant Staphylococcus aureus Clone in Northern Australia
McGuinness, SL; Holt, DC; Harris, TM; Wright, C; Baird, R; Giffard, PM; Bowen, AC; Tong, SYC
(2021), mSphere
Time for universal hepatitis B screening for Australian adults
Allard, NL; MacLachlan, JH; Tran, L; Yussf, N; Cowie, BC
(2021), Med. J. Aust., 103
DOI: 10.5694/mja2.51114
Australia needs a prioritised national research strategy for clinical trials in a pandemic: lessons learned from COVID-19
Bowen, AC; Tong, SYC; Davis, JS
(2021), Med. J. Aust., 56
DOI: 10.5694/mja2.51143
Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria
Woolley, SD; Marquart, L; Woodford, J; Chalon, S; Moehrle, JJ; McCarthy, JS; Barber, BE
(2021), Malar. J.
Between a rock and a hard place: COVID-19 vaccination and patients on rituximab therapy
Teh, BW; Tam, CS
(2021), Leuk. Lymphoma, 2820-2822
Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study
Muhi, S; Tayler, N; Hoang, T; Ballard, SA; Graham, M; Rojek, A; Kwong, JC; Trubiano, JA; Smibert, O; Drewett, G; James, F; Gardiner, E; Chea, S; Isles, N; Sait, M; Pasricha, S; Taiaroa, G; McAuley, J; Williams, E; Gibney, KB; Stinear, TP; Bond, K; Lewin, SR; Putland, M; Howden, BP; Williamson, DA
(2021), Lancet Reg. Health-W. Pac.
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study
McCarthy, JS; Yalkinoglu, O; Odedra, A; Webster, R; Oeuvray, C; Tappert, A; Bezuidenhout, D; Giddins, MJ; Dhingra, SK; Fidock, DA; Marquart, L; Webb, L; Yin, XY; Khandelwal, A; Bagchus, WM
(2021), Lancet Infect. Dis., 1713-1724
Typhoid fever in travellers: estimating the risk of acquisition by country
Forster, DP; Leder, K
(2021), J. Travel Med.
DOI: 10.1093/jtm/taab150
Cerebral melioidosis in an immunocompromised traveller: an argument for prevention
Lim, K; McShane, L; Rees, M; Muhi, S
(2021), J. Travel Med.
DOI: 10.1093/jtm/taaa187
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy
Stern, J; Solomon, A; Dantanarayana, A; Pascoe, R; Reynaldi, A; Davenport, MP; Milush, J; Deeks, SG; Hartogensis, W; Hecht, FM; Cockerham, L; Roche, M; Lewin, SR
(2021), J. Infect. Dis., 1721-1730
Impact of time to first antimicrobial dose on length of stay and 30-day hospital readmission in patients with lower limb cellulitis
Bishop, JL; Jones, M; Farquharson, J; Summerhayes, K; Tucker, R; Smith, M; Cowan, R; Friedman, ND; Schulz, TR; Kong, DCM; Buising, KL
(2021), J. Glob. Antimicrob. Resist., 367-369
Investigating virus-host cell interactions: Comparative binding forces between hepatitis C virus-like particles and host cell receptors in 2D and 3D cell culture models
Collett, S; Torresi, J; Silveira, LE; Truong, VK; Christiansen, D; Tran, BM; Vincan, E; Ramsland, PA; Elbourne, A
(2021), J. Colloid Interface Sci., 371-384
A Survey on Knowledge Gaps in Assessment and Management of Severe Drug Hypersensitivity Reactions: Multicenter Cross-Sectional Study of Australian Health Care Providers
Mazzoni, D; Tee, HW; de Menezes, SL; Graudins, LV; Johnson, DF; Newnham, ED; Kelley, PG; Zubrinich, CM; Goh, MSY; Trubiano, JA; Aung, AK
(2021), J. Clin. Pharmacol., 25-31
DOI: 10.1002/jcph.1692
Seeking an optimal dosing regimen for OZ439/DSM265 combination therapy for treating uncomplicated falciparum malaria
Dini, S; Zaloumis, SG; Price, DJ; Gobeau, N; Kummel, A; Cherkaoui, M; Moehrle, JJ; McCarthy, JS; Simpson, JA
(2021), J. Antimicrob. Chemother., 2325-2334
DOI: 10.1093/jac/dkab181